临床阶段的Nrf2激活剂通过铁-甲基因轴抑制骨质细胞分化
Yimin Dong1, Honglei Kang1, Renpeng Peng1
1Department of Orthopaedic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Cell metabolism
|April 3, 2024
概括
比托珀丁是一种新型Nrf2激活剂,通过抑制骨质细胞分化和骨质损失来治疗骨质疏松症. 这种糖氨酸吸收抑制剂的副作用比现有治疗方法少,揭示了一个新的Nrf2-铁-甲尼丁通路.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 激活Nrf2 (核因素红色素2相关因子2) 是绝经后骨质疏松症的治疗策略.
- Nrf2调节骨质细胞分化的精确机制尚未完全理解.
- 目前还没有批准的Nrf2激活剂用于治疗慢性疾病.
研究的目的:
- 为了研究比托珀丁的潜力,一种甘氨酸吸收抑制剂,作为治疗骨质疏松症的Nrf2激活剂.
- 阐明Nrf2在骨质细胞分化中的作用背后的分子机制.
- 确定骨质疏松症治疗的新型治疗点和途径.
主要方法:
- 在骨质细胞分化的体外研究.
- 使用卵巢切除诱导的骨质疏松症小鼠模型的体内研究.
- 对Keap1-Nrf2相互作用,蛋白质无处不在和降解的分析.
- 对Slc40a1和Odc1.1的基因表达分析.
- 在骨质细胞中评估细胞内铁和甲素水平.
主要成果:
- 比托珀丁通过抑制Keap1-Nrf2结合,减少Nrf2降解和抑制骨质细胞分化来激活Nrf2.
- 比托珀丁改善了小鼠的卵巢切除诱导的骨损失.
- 比托珀丁在小鼠和人类中与现有的Nrf2激活剂相比,具有有利的安全性.
- Nrf2上调Slc40a1,在骨质细胞中降低细胞内铁.
- 降低Nrf2或补充铁可以增加Odc1,降低甲状腺蛋白,促进骨质细胞分化.
结论:
- 比托珀丁是一种新型的临床阶段Nrf2激活剂,可以有效治疗骨质疏松症.
- 已经确定了一种新的Nrf2-调节的代谢轴,涉及骨质细胞中的铁和甲.
- 比托珀丁是绝经后骨质疏松症的一种有前途的治疗候选药物,具有潜在的安全性.
相关概念视频
Co-activators and Co-repressors
7.3K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.3K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Necrosis
4.5K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.5K
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K


